Clinical Trials Logo

Filter by:
NCT ID: NCT00275379 Withdrawn - Clinical trials for Cystitis, Interstitial

Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis

Start date: August 2006
Phase: N/A
Study type: Interventional

This is a multicenter, randomized, double-blind, placebo-controlled, parallel-design, exploratory study of orally administered ERB-041 in subjects with active IC. The primary objectives of this study will be to investigate ERB-041's activity on levels of urinary APF, explore the gene expression response in peripheral blood mononuclear cells (PBMC), and to evaluate the safety of ERB-041 in women with active IC.

NCT ID: NCT00273234 Withdrawn - Venous Ulcer Clinical Trials

Clinical Effectiveness of Topical Autologous Platelet Gel for the Treatment of Venous Ulcers

Start date: January 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the effectiveness of standard venous ulcer care to standard venous ulcer care plus a cell based product made from the patients own blood. This product, Autologous Platelet Concentrate (APC), is a concentrate of cells in the bloodstream called platelets.

NCT ID: NCT00265408 Withdrawn - Ischemic Stroke Clinical Trials

Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection

Start date: December 2005
Phase: Phase 1
Study type: Interventional

Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection.

NCT ID: NCT00262496 Withdrawn - Clinical trials for Urinary Incontinence

Botulinum-A Toxin Injection for Detrusor Hyperreflexia in Spinal Cord Injury: A Non-Surgical Approach.

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of the study is to determine whether Botulinum-A toxin injected in the bladder muscle will help prevent the frequency and degree of urinary incontinence in Spinal Cord Injured and Multiple Sclerosis patients. The proposed mechanism would be that the Toxin would allow the bladder to hold more urine at a lower pressure as determined by Urodynamics. The research will answer the question whether the dosages 300 units vs 400 units are either equally vs not equally effective in helping urinary incontinece and bladder storage.

NCT ID: NCT00262457 Withdrawn - Spinal Cord Injury Clinical Trials

BIONs, for Improved Tissue Health and Pressure Sore Prevention

Start date: April 2004
Phase: N/A
Study type: Interventional

The purpose of this study was to determine the feasibility of an implanted electrical stimulation system incorporating BION microstimulators for long term use to prevent tissue breakdown in high risk patients.

NCT ID: NCT00261196 Withdrawn - Adhesive Capsulitis Clinical Trials

Collagenase in the Treatment of Adhesive Capsulitis (Frozen Shoulder)

Start date: January 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test collagenase injection therapy to dissolve adhesions causing frozen shoulder.

NCT ID: NCT00260052 Withdrawn - Clinical trials for Traumatic Brain Injury

Erythropoietin Effects After Traumatic Brain Injury

Start date: July 2003
Phase: Phase 2/Phase 3
Study type: Interventional

To determine if the early administration of erythropoietin to patients sustaining traumatic brain injury will reduce secondary brain injury.

NCT ID: NCT00259636 Withdrawn - Fibromyalgia Clinical Trials

Zonisamide for Fibromyalgia & Migraine

Start date: August 2004
Phase: Phase 4
Study type: Interventional

Patients with fibromyalgia & migraine are randomized to receive zonisamide or placebo.

NCT ID: NCT00256841 Withdrawn - Clinical trials for Carcinoma, Non-Small-Cell Lung

Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy

Start date: September 2005
Phase: Phase 1/Phase 2
Study type: Interventional

The study is designed for patients with non small cell lung cancer whose cancer is too advanced and therefore cannot be operated with the goal of completely removing the cancer. At this stage of the disease, most patients cannot be cured from the disease, however, treatment can help to live longer and better by keeping the cancer under control. For that purpose, patients traditionally receive radiation therapy or chemotherapy or both treatments in succession. Recently, the administration of both treatment methods given concurrently showed somewhat better results when compared to successive administration. In some studies the drug Taxotere together with radiation performed well in keeping the cancer better under control. Combination of the drug Taxotere together with a compound called 5-FU either as continuous infusion or in its oral form of a pill called "Xeloda" enhanced its anti cancer activity substantially. One goal of this study is to investigate how much of the combination can be given in conjunction with chest radiation. Using X-rays, the study will also evaluate how much shrinkage of the cancer is caused by this treatment directly at the tumor site and other areas where the cancer may have also spread. In this study the radiation will be given on only one day per week in two sessions, rather than divided over five days per week (Monday through Friday) as it is more commonly used. However, both schedules have been found to be equally effective. The treatment program will use increasing doses of the 5-FU medication, either as infusion or as pill to find the highest dose that is tolerated. Once the highest tolerated dose is determined, subsequent patients who will be enrolled will continue to be treated at that dose level. The dose of the drug Taxotere will remain the same throughout. Hypothesis: Our previous research suggests that the combination of Taxotere and 5-FU given together with weekly chest radiation will provide a more convenient form of treatment than the conventional approach and also be at least similar in its efficacy.

NCT ID: NCT00255138 Withdrawn - Cancer Clinical Trials

Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects

Start date: November 2005
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate the effectiveness and safety of atomoxetine in enhancing attention and concentration among childhood survivors of cancer.